With the political landscape changing quickly in Washington DC, there seems to be a lull in activity surrounding the FDA Globalization Act of 2008. Representative Dingell, the original proponent of the act, has been replaced by Representative Waxman as the the Chairman of the Energy and Commerce Committee (the Committee overseeing the FDA Globalization Act). With Representative Waxman comes an entirely new agenda that may or may not have the FDA Globalization Act (in some shape or form) on it. For now, it appears to be off the active agenda table and literally, tabled for 2008.
Bramble Berry and a coalition of fellow vendors (Essential Wholesale, WholesaleSuppliesPlus), active micro businesses (Belle Lucce, j.blossom) and industry groups (The Soap Guild, Indie Beauty Network) are continuing to monitor the situation, actively brainstorm solutions and proactively educate friends and customers how to best comply with current laws and best manufacturing practices.
To see previous posts about this (including a round up of the Washington DC trip) click here.
